EUROPEAN COMMISSION-CORDIS: TOP STORY-PROJECT SUCCESS STORIES-IN SILICO MEDICINE REACHES THE CLINIC
Updated: Nov 5, 2018
Forget the monopoly of in vitro, the study of biology in test tubes. The real cutting edge of medical science is in silico, and European researchers have just achieved a world first in the field. ...
The oncosimulator: cancer in silico
And ACGT's most innovative and advanced support tool is its oncosimulator, a piece of mathematical modelling, simulation and visualisation software and an in silico experimental platform.
The In Silico Oncology Group is developing this platform in collaboration with several research centres in Europe and Japan under the lead of Research Professor Georgios Stamatakos of the Institute of Communication and Computer Systems (ICCS) at the National Technical University of Athens (NTUA).
'The oncosimulator is an integrated software system simulating in vivo tumour response to therapeutics within a clinical trial environment,' explains Prof. Graf. 'It aims to support clinical decision-making for individual patients. Cancer treatment optimisation is the main goal of the system.'